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Abstract
Background: Two annual surveys, the abattoir and the fallen stock, monitor the presence of
scrapie across Europe. A simple comparison between the prevalence estimates in different
countries reveals that, in 2003, the abattoir survey appears to detect more scrapie in some
countries. This is contrary to evidence suggesting the greater ability of the fallen stock survey to
detect the disease. We applied meta-analysis techniques to study this apparent heterogeneity in the
behaviour of the surveys across Europe. Furthermore, we conducted a meta-regression analysis to
assess the effect of country-specific characteristics on the variability. We have chosen the odds
ratios between the two surveys to inform the underlying relationship between them and to allow
comparisons between the countries under the meta-regression framework. Baseline risks, those of
the slaughtered populations across Europe, and country-specific covariates, available from the
European Commission Report, were inputted in the model to explain the heterogeneity.
Results: Our results show the presence of significant heterogeneity in the odds ratios between
countries and no reduction in the variability after adjustment for the different risks in the baseline
populations. Three countries contributed the most to the overall heterogeneity: Germany, Ireland
and The Netherlands. The inclusion of country-specific covariates did not, in general, reduce the
variability except for one variable: the proportion of the total adult sheep population sampled as
fallen stock by each country. A large residual heterogeneity remained in the model indicating the
presence of substantial effect variability between countries.
Conclusion: The meta-analysis approach was useful to assess the level of heterogeneity in the
implementation of the surveys and to explore the reasons for the variation between countries.
Background
Scrapie is a fatal neurological disease affecting small rumi-
nants. It belongs to the group of diseases known as trans-
missible spongiform encephalopathies (TSE) that among
others include bovine spongiform encephalopathy (BSE)
in cattle and Creutzfeldt-Jakob disease (CJD) in humans.
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BSE was first detected in 1986 and was shown to spread
between cattle by contaminated concentrate [1]. In 1996
it became clear that BSE could be transmitted to humans
giving rise to variant CJD [2]. Throughout Europe, scrapie
has acquired increased interest because it is considered a
potential threat to public health after the successful exper-
imental transmission of BSE to sheep [3] and the likely
exposure of sheep to concentrate feed contaminated with
the BSE agent [4]. In order to obtain better estimates of the
scrapie prevalence throughout the EU, active surveillance
for scrapie in small ruminants was introduced in 2002.
The surveillance comprised both slaughtered and found-
dead animals, namely the abattoir (AS) and fallen stock
(FS) surveys respectively [5].
A set of regulations established a regime of procedures
that each EU Member State had to follow: i) the sample
sizes should be sufficient to detect a prevalence of 0.005%
and 0.05% in the populations of slaughtered and found-
dead animals, respectively, ii) the target populations were
animals older than 18 months of age in both surveys
based on dentition checks or any other obvious sign of
maturity, and iii) the surveys should be as representative
as possible of all breeds, regions and any other character-
istic defining some stratification in the standing popula-
tion. Furthermore, four screening tests for the rapid
detection of scrapie in small ruminants were applied con-
sistently throughout the EU during 2003: two Enzyme-
Linked ImmunoSorbent Assays (ELISA) tests, a lumines-
cence immunoassay test and a Western-blot based test.
The consistent application of these procedures by all
Member States should guarantee a certain level of homo-
geneity in the implementation of the testing across
Europe. This would allow fair comparisons between the
EU countries with the confidence that the surveys' results
do not reflect the effect of artefacts, for example differ-
ences in the implementation of the surveys, but true dif-
ferences in the underlying prevalence of scrapie between
countries.
In 2003 the EU Commission Report on the monitoring
for the presence of scrapie [6] reported large variation in
the frequency estimates of the two surveys between coun-
tries. In most of the countries the frequency estimates
from the FS were larger than those of the AS. In other
countries, however, the FS seemed to detect less scrapie
than the AS. This pattern is inconsistent with other works
that reported the increased risk of scrapie among the dead
on farm animals [7,8] and suggests the occurrence of het-
erogeneity in the implementation of the surveys between
countries; surveys may be reflecting either different situa-
tions (e.g. different risks affecting the target individuals by
the surveys, tests with different characteristics) or differ-
ences in their methodological implementation. There is a
need to inform any comparisons between the detected
prevalences in the individual surveillance streams.
There have been previous attempts to inform these com-
parisons. Bird [9] compared the surveillance performance
of the two active surveillance sources among EU countries
for BSE and scrapie in cattle and sheep respectively. Bird
used the tests results from 2001 and 2002, as reported by
the EU Commission, to calculate the BSE and TSE rate
ratios for each country to describe differences and anom-
alies in the implementation of the surveys. Bird also pro-
duced a EU-pooled measure of the rate ratios between
surveillance streams: the median TSE prevalence rate ratio
(fallen sheep vs. slaughtered). For the period April to
August 2002, Bird reported a rate ratio of 7, which indi-
cated some conformity with the reported 10 times higher
prevalence in the fallen stock group for cattle [10]. This
increased "efficacy" of the FS is consistent with other
works on sheep scrapie [7,8].
Following an approach similar to that of Bird [9], the
comparison of some form of frequency ratio between the
two surveys throughout the EU, under the standard condi-
tions that apply to the surveys' operations, appears as an
adequate methodology to assess the comparability of the
scrapie surveillance across Europe. Exploring any differ-
ences in the ratios is important because it might help in
the understanding of the performance of the surveillance
programmes. This might be used to improve the pro-
grammes themselves.
The objective of this work is to study the apparent hetero-
geneity in the behaviour of the surveys across Europe and
to investigate the sources of this heterogeneity by taking
into account available country-level covariates, poten-
tially explaining methodological differences in the imple-
mentation of the surveys, and the effect of the underlying
risk in the slaughtered sheep population.
Results
The test for heterogeneity was significant (Q = 108.6, df =
13, p < 0.0001). Higgins and Thompson [11] statistic sug-
gested that most of the total variation in the estimates of
effect was due to the heterogeneity between countries (I2
= 88%, 95% confidence intervals: 82–92).
The forest plot for the random effects meta-analysis of the
14 countries dataset is shown in Figure 1. The pooled
effect, the exponentiated logOR, was 3.3 (95% confidence
intervals: 1.57–7.08). Germany, The Netherlands, Czech
Republic and Sweden showed a better performance of the
abattoir survey relative to the fallen stock in detecting
cases of scrapie, but the 95% confidence intervals for all
included 1. Slovakia, Belgium (although these two with
large confidence intervals due to the small numbers), Ire-BMC Veterinary Research 2007, 3:13 http://www.biomedcentral.com/1746-6148/3/13
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land and Norway showed the best performance of the
fallen stock survey in capturing cases of scrapie relative to
the abattoir survey.
As illustrated by the Galbraith plot (Figure 2), seven coun-
tries (Belgium, Slovakia, Portugal, Sweden, Italy, Spain
and the UK) appeared within the 95% confidence interval
of the unweighted regression line representing the overall
logOR in a fixed effects (assuming no heterogeneity)
meta-analysis. Ireland, The Netherlands and Germany
were the countries that contributed the most to the
between-country heterogeneity given their departure from
the 95% confidence interval.
The meta-analysis carried out under the Bayesian frame-
work, on the 18 countries and applying binomial likeli-
hood, allowed the estimation of the uncertainty around
the between country heterogeneity (τ = 1.73 (95% credi-
ble intervals: 0.98, 3.47). The inclusion of the four coun-
tries with zero values in both surveys reduced the overall
OR (2.61, 95% credible intervals: 0.67, 7.32).
The results of the meta-regression analysis showed that
the regression coefficients (β) for "test" and "repreAS"
included zero in their 95% credible intervals. Their effect
on the heterogeneity was not significant.
"repreFS" appeared significantly related to the outcome (β
= -1.96, 95% credible intervals: -3.82, -0.47). This covari-
ate managed to explain over 18% of the between country
heterogeneity (τ  = 1.42, 95% credible intervals: 0.79,
2.91) when compared to the crude model. Adjusting for
the AS-baseline did not appear to have a significant effect
in the overall heterogeneity of the model.
Discussion
We have shown the application of a proven methodology,
the meta-analysis framework, to an unusual setting. This
has demonstrated the occurrence of great heterogeneity in
our measure of choice, the odds ratios between the two
surveys, across countries. This can be interpreted as the
presence of variability in the way the surveys, across the
EU, seem to inform the underlying prevalence of scrapie.
There have been previous attempts to compare the infor-
mation from the TSE testing results in the EU [9]. This
study, however, could not take into account the potential
heterogeneity in the surveys' behaviour between countries
because of the preliminary nature of the data. Green [12]
stated that the detailed description of the design and pro-
cedures for case ascertainment should be performed
before any comparisons or pooling of estimates was
attempted. This is in line with the objective of this paper.
As a by-product, we obtained the overall intervention
effect, the pooled OR across Europe. Our results show that
scrapie-affected sheep were, on average, 3.3 times more
likely to be detected by the fallen stock survey than the
abattoir survey throughout Europe. This seems to differ
Galbraith plot Figure 2
Galbraith plot. Galbraith plot. The log-odds ratios (b) 
divided by their standard errors of the 14 countries (after 
excluding those countries with zero counts in both surveys) 
are plotted against the reciprocal of the standard errors 
(horizontal axis). Solid lines represent the unweighted 
regression line constrained at 0 with a slope equal to the 
overall logOR of a fixed effects meta-analysis on our data, 
and its 95% confidence intervals. The position of the coun-
tries in the y-axis indicates their contribution to the Q statis-
tic for heterogeneity. The position of the countries on the x-
axis indicates the weight of each country in the meta-analysis.
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Forest plot Figure 1
Forest plot. Forest plot of the odds ratios (FS/AS) assuming 
random effects. Only 14 countries after removal of those 
with zero counts in both surveys. The solid vertical line is 
showing an odds-ratio of 1 (no effect). The contribution of 
each country (weights) to the meta-analysis is represented by 
the area of the box in the plot. The diamond at the bottom 
shows the overall treatment effect. Weights are derived 
from the Mantel-Haenszel method.
  Odds ratio
 .002002  1  499.267
Country
  Odds ratio
 (95% CI)  % Weight
 Germany   0.60 ( 0.26, 1.40)   8.8 
 Greece   7.57 ( 4.09, 14.00)   9.3 
 Spain   1.62 ( 0.71, 3.71)   8.8 
 France   1.74 ( 1.12, 2.71)   9.6 
 Ireland   36.23 ( 16.26, 80.71)  8.9 
 Italy   6.52 ( 3.06, 13.88)   9.0 
 Netherlands   0.70 ( 0.30, 1.65)   8.8 
 Slovakia   18.34 ( 1.14, 294.16)  4.2 
 Norway   15.93 ( 5.21, 48.72)   8.1 
 UK   4.09 ( 2.20, 7.58)   9.3 
 Czech Rep.   0.06 ( 0.00, 1.38)   3.6 
 Sweden   0.36 ( 0.02, 7.57)   3.8 
 Portugal   3.38 ( 0.19, 60.19)   4.0 
 Belgium   23.93 ( 1.15, 499.27)  3.8 
Overall   3.33 ( 1.57, 7.08)  100.0 BMC Veterinary Research 2007, 3:13 http://www.biomedcentral.com/1746-6148/3/13
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significantly from the expected 10 times higher prevalence
from the fallen stock group, by analogy with BSE, as antic-
ipated by the European Scientific Steering Committee
(ESSC) [10]. However, the presence of significant hetero-
geneity prevents one from drawing conclusions on an
overall effect. This is true in the case of the meta-analysis
and valid too for the meta-regression models where sub-
stantial heterogeneity remained.
Kuhnert and Böhning [13] described the occurrence of
two types of heterogeneity potentially present in any
meta-analysis: the effect heterogeneity and the baseline
heterogeneity. The former seems to dominate in our set-
ting after adjusting for the covariates and the baseline var-
iability. Our binomial approach did not return a
significant effect of the baseline risks on the model heter-
ogeneity. Binomial approaches are reported to be more
appropriate when facing sparse data but they would still
require caution in their interpretation [14]. The sensitivity
of our results, due to the rarity of our data, to likelihood
assumptions was evident when we modelled the data, the
14 countries with the 0.5 continuity correction, under a
normal likelihood. In this situation, adjusting for the var-
iability in the baseline risks managed to reduce signifi-
cantly the model's heterogeneity (β = -0.94, 95% credible
intervals: -1.88, -0.05).
From the meta-regression approach we can conclude that
only the variable "repreFS" appeared to have a significant
relationship with the outcome. It also managed to explain
some of the between-country heterogeneity in the model.
The negative slope, the β coefficient for "repreFS" (-1.96),
indicates that the greater the proportion of the total adult
sheep population sampled by the FS, the lesser the ability
of this source in detecting cases of scrapie, relative to that
of the abattoir survey. One explanation for this is that
some animals that did not fall within the scope of the
fallen stock group might have been reported under this
surveillance stream introducing an unquantifiable selec-
tion bias in the tested population. This would produce a
dilution effect, a reduction of the "high risk" nature of this
group, reducing the prevalence estimates observed. The
fallen stock figures from Germany, for example, might fol-
low this logic. The Food and Veterinary Office (FVO) mis-
sion to Germany in November 2002 highlighted the
subsidised collection service for the dead on farm animals
and the sampling of some fallen stock sheep over 12
months of age [15]. Likewise, the simple observation of
Table 1 shows that those countries with smaller samples
in the FS seem to detect more scrapie than those with
larger samples. We cannot discard the presence of the so
called "small-study effects" described in the systematic
review literature by which small studies tend to show
lower methodological quality and larger effects [16].
Alternatively, the increased risk of scrapie among the
slaughtered population, relative to that of the fallen stock
group, could also explain the negative logOR of some
countries (Table I). If animals from scrapie affected hold-
ings, which had been slaughtered out, were included in
the slaughtered population, as culls, this might have
Table 1: Survey data by country
Countries rA nA rF nF LogOR Variance Adult sheep (000) RepreFS RepreAS test
Belgium 0 2376 2 494 3.18 2.40 146 0.34 1.63 1
Denmark 0 871 0 1320 N/A N/A 105 1.26 0.83 0.13
Germany 9 20107 13 48616 -0.52 0.19 2637 1.84 0.76 0.91
Greece 49 22564 13 780 2.04 0.10 9042 0.01 0.25 0.43
Spain 19 49921 8 12942 0.48 0.18 23045 0.06 0.22 -
France 46 44641 34 18955 0.55 0.05 8962 0.21 0.50 0.49
Ireland 9 51579 18 2830 3.60 0.17 5907 0.05 0.87 1
Italy 14 35260 13 5011 1.88 0.15 7952 0.06 0.44 0.12
Luxembourg 0 213 0 244 N/A N/A 7 3.49 3.04 1
Netherlands 45 21095 6 3994 -0.35 0.19 1276 0.31 1.66 0
Austria 0 4225 0 3255 N/A N/A 304 1.07 1.39 0
Portugal 6 10697 0 243 1.22 2.16 3411 0.01 0.31 1
Finland 0 1990 0 683 N/A N/A 67 1.02 2.97 0.71
Sweden 2 5175 0 2849 -1.01 2.40 451 0.63 1.15 1
UK 45 72473 13 5113 1.41 0.10 24574 0.02 0.30 0.89
Chzech Rep 1 425 0 2528 -2.88 2.67 103 2.45 0.41 -
Slovakia 1 3923 1 213 2.91 2.00 325 0.07 1.21 -
Norway 5 33519 8 3359 2.77 0.33 928 0.36 3.61 1
rF shows the number of positive samples from the fallen stock, rA shows the number of positive samples from the abattoir survey, nF shows the 
number of samples tested in the fallen stock and nA the number of samples tested in the abattoir survey. LogOR (log (odds fallen stock/odds abattoir 
survey)), variance of the logOR (calculated as 1/rA + 1/nA + 1/rF + 1/nF) with 0.5 continuity correction added to all denominators for those countries 
with one 0 in any of the columns (rF, rA, nF, nA), adult sheep population by country and country-specific covariates inputted into the meta-regression 
model: "repreFS" (proportion of the adult sheep population sampled by the FS), "repreAS" (proportion of the adult sheep population sampled by the 
AS) and "test" (proportion of ELISA tests over all samples tested). N/A under the logOR and variance headings show those countries with zero 
counts in both surveys.BMC Veterinary Research 2007, 3:13 http://www.biomedcentral.com/1746-6148/3/13
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increased the risk of scrapie within this group. The 2003
Report [6] stated that, in the context of the eradication
measures, a within-holding prevalence of 3% was
detected. Similar effects would be observed if the farmers
did not submit the found-dead animals, which have
shown scrapie-like signs, as fallen stock; in itself another
form of selection bias.
None of the other covariates ("repreAS" and "test")
showed a significant effect on the heterogeneity. The data
provided by most countries on the use of the rapid tests
drove the current parameterisation of this variable as the
most comprehensive. Other parameterisations did not
produce any different results. Although for nine countries
only, "test", as the ratio of ELISA tests used in each survey
by each country, did not reduce τ either. Our analyses do
not capture all the potential variability from the use of the
four screening tests across the EU. More data on the use of
the screening tests by the countries would be required to
improve on the present work.
Other country-specific covariates might inform some of
the remaining variability left in the model. However, the
amount of information recorded in the European Com-
mission's report [6] was modest. Extra variables to feed
into the meta-regression approach, e.g. characteristics
related to the operational implementation of the surveys
or those that would allow a different parameterisation of
the test variability (of special interest would have been
those related to the application of the confirmatory tests
between the countries), might have explained some fur-
ther methodological heterogeneity. Genotype informa-
tion, if available, should always be taken into account in
any scrapie-related analyses; such is the importance of this
variable in the susceptibility to scrapie. Although geno-
type data, from an apparent random subset of the AS, was
available from [6], only 5 countries genotyped the 500
sheep suggested by the ESSC [10]. We did not believe
there was enough data to inform this variable and decided
not to use it in our analyses. In the absence of more cov-
ariate information, a meta-analysis of the cluster structure
of the data, identifying clusters of studies with similar
ratios, has been suggested recently to explore the unob-
served heterogeneity [13].
The use of a full Bayesian approach is justified by the very
same limitations that characterise the traditional weighted
regression approach: i) normal likelihood assumption of
the measure of effect ii) asymptotic confidence intervals
and iii) estimation of τ from the data as if it was the true
heterogeneity in the population. This was evident after
checking the asymmetry of the 95% credible intervals
around the posterior estimates for τ. This alone would jus-
tify the use of a non-asymptotic approach [17].
Other measures of effect could have been chosen: risk
ratio or risk difference. However, the mathematical prop-
erties of the odds-ratios (with values from 0 to infinity),
the lesser heterogeneity displayed by them (when com-
pared to the risk difference) [18] and, for the Bayesian
inference, a posterior distribution close to normal even
for the sparse data we faced, outweighed any of the other
two. Furthermore, the choice of continuity corrections for
normal approximations, in our case 0.5, together with the
scale of the measure of effect (e.g. a log scale) is likely to
have influenced our results [28,31]. For example, the
application of the reciprocal of the opposite treatment
arm size (FS in our case) as continuity correction [28]
returned a pooled OR of 4 (95% confidence intervals: 1.8
– 8.8). The former would also support the use of the bino-
mial likelihood to model our data. This is particularly so
when the numbers in the two groups, abattoir and fallen
stock, were very imbalanced and the data very sparse [28].
Flat priors were used for all parameters in our Bayesian
models. The choice of priors is of great importance, partic-
ularly for the variance components [19]. Sensitivity anal-
yses were carried out checking the effect of our choice of
priors upon the results. We could not find any significant
difference as a result of using different prior distributions.
Caution should also be exercised due to the observational
nature of the meta-regression as such. The relationship
described by meta-regression does not have the benefit of
randomisation to back the interpretation of the results.
Any association identified with one country characteristic
may in reality reflect a true association with other corre-
lated characteristics, which are likely to be unknown [20].
As a reflection of the increasing number of countries
reporting the occurrence of atypical cases of scrapie that
produce discordant responses to the established diagnos-
tic tests [21,22], the European Commission's Report [6]
clearly stated that all four cases in Sweden and 14 of the
15 from Norway were identified as of the Nor98 type [23].
We did not make any discrimination between the two
types of scrapie: the classical and the atypical. Rather, we
considered them together for simplicity and to avoid any
further layer in our already scarce data. We cannot ignore
however the potential contribution of this joint approach
to the overall heterogeneity. Multivariate analyses for
more than one outcome would be required if the two
scrapie types were studied separately [24].
Further studies should look at ways of incorporating more
than one year's surveillance data together with the incor-
poration of more sources of surveillance, namely the stat-
utory reporting and those figures from the eradication
measures upon the scrapie affected holdings. This wouldBMC Veterinary Research 2007, 3:13 http://www.biomedcentral.com/1746-6148/3/13
Page 6 of 8
(page number not for citation purposes)
allow extending this comparison process to the entire sur-
veillance network.
Conclusion
The meta-analysis of the odds ratios between the two sur-
veys proved a valid and systematic approach to inform the
presence of heterogeneity in the operation of the surveys
and to identify those countries with the greatest contribu-
tion to this variability. The extension of the analysis to a
meta-regression allowed the assessment of the effect of the
available covariates on the overall heterogeneity.
Although substantial heterogeneity remained in the
model, unexplained by the scarce data available, there
appears to be a need to standardise further the approach
to the surveys by the Member States.
Methods
Data
Data on the number of sheep tested and confirmed by
each surveillance source (AS and FS) were collected from
the EU's annual report on the monitoring of transmissible
spongiform encephalopathy (TSE) in ruminants in 2003
[6]. Data from 18 European countries were available for
the study (Table 1). Data on the screening tests used by
each country were not available in the Commission
Report nor was possible to obtain them from the Com-
mission due to confidentially issues. Under the collabora-
tion framework of the NeuroPrion Network of Excellence,
we requested these data from the National Institutes/Ref-
erence Laboratories of all the 18 Member States listed in
the report. We did not obtain data from three countries
(Czech Republic, Slovakia, and Spain).
Measures of effect
The number of positive and negative samples for each sur-
vey and country can be represented in the form of a 2 × 2
table. Odds ratios (OR) between the fallen stock and the
abattoir survey are selected and applied in their logarith-
mic form: logOR. Table 1 shows the logOR for each coun-
try together with their variance.
Meta-analysis
We used meta-analysis methodologies, and more specifi-
cally, meta-regression techniques to explain the variability
between countries in this particular context. Meta-analysis
is well suited to explore reasons for variation in the
observed effect among studies [25]. Other studies have
recognised the explanation of the heterogeneity between
studies as a logical step and one of increasing importance
when conducting meta-analyses [17,26]. If we make the
equivalence of countries to studies or centres, the typical
study units in traditional meta-analyses, we can run com-
parisons between countries under the meta-analysis
framework.
We first conducted a random effects meta-analysis of the
logOR in Stata 8.2 (Stata Corporation, College Station,
Texas) to study the presence of heterogeneity. A statistical
test of heterogeneity is given in the form of the Q statistic,
which has a Chi-square distribution with k-1 (k = number
of studies/countries) degrees of freedom [25]. We com-
pared the logORs of the different countries under the
assumption that the effects were exchangeable, i.e. the
logORs were assumed to be randomly drawn from a pop-
ulation distribution. The random effects model was run
using the method of DerSimonian and Laird [27], with
the estimate of heterogeneity being taken from the Man-
tel-Haenszel approach which has been suggested as more
adequate for studies with zero events [28]. The traditional
random effects model follows
Yi ~ Normal(θi, vi) θi ~ Normal(µ, τ2)( 1 )
for i = 1,2.... N studies, where Yi is the observed effect (the
logOR) in the ith study/country with variance vi and θi the
study/country specific effects which are sampled from a
Normal distribution with mean µ  and variance τ2, the
between-country heterogeneity.
The quantification of the impact of the between-country
variability on the results of the meta-analysis was meas-
ured by Higgins and Thompson statistic (I2) [11]. Further-
more, forest plots and Galbraith plots [29] (to display
graphically the amount of heterogeneity that individual
countries contribute) were used to visually help in the
interpretation of the data.
To avoid the logOR become undefined for the countries
with zero count in either of the surveillance sources [20]
we applied a 0.5 continuity correction. Furthermore, to
avoid that all the observed effects for a country come from
the continuity correction applied, we excluded all those
countries with zero counts in both surveys from this part
of the analysis. This restricted this analysis to 14 countries
after the exclusion of Austria, Denmark, Finland and Lux-
embourg.
To circumvent the above limitations, the need for conti-
nuity corrections and the normality assumption for scarce
data, we conducted a second set of analyses following
Bayesian methods. We performed the analysis assuming
that the observed number of events (samples tested posi-
tive) in both groups (abattoir survey ( ) and fallen stock
( )) followed a binomial distribution [30]
ri
A
ri
F
r Binomial p n i N
r Binomial p n
i
A
i
A
i
A
i
F
i
F
i
~ ( , ) ,...
~( ,
=1  countries
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where, for the ith country,   and   are the number of
samples tested in the two surveys and   and   are the
underlying probabilities of a positive sample in the two
surveys. Furthermore, we express these probabilities,
under a logistic regression approach, as
where, for the ith country, ϕi is the estimated log-odds of a
positive sample in the abattoir survey (called the "baseline
risk"), θi is the logOR between the two surveys (also called
the "treatment effect") and µ and τ2 have the same inter-
pretation as in equation (1). A normally distributed, non-
informative prior is regularly assigned to µ (Normal (0,
10000)) and a Uniform prior, non-informative, to τ2
(Uniform(0,10)). Sensitivity analysis, to the choice of pri-
ors, is regularly conducted by changing the prior distribu-
tions for τ2, for example to a Normal(0, 10000) zero
truncated. We assumed independent baselines between
countries dismissing thus any relationship or overall dis-
tribution across the underlying risks. We allocated a non-
informative prior to the underlying baseline risks ϕi: Nor-
mal(0, 100). An important advantage of the binomial
approach is that we can use all data points, the 18 coun-
tries, regardless of the presence of zero counts in the two
surveillance sources. Another important benefit from the
use of a Bayesian approach is the estimation of the credi-
ble intervals around the point estimate of τ2 as this is now
treated as a random variable with uncertainty in its esti-
mation [31].
Meta-regression
In the presence of heterogeneity, pooled/overall estimates
of effect should not be reported. The aim should shift to
explain the causes of variability between studies. Meta
regression aims to explain, by the inclusion of country-
specific covariates, the heterogeneity of the effects
between countries. Some of this variability may have
come from the different screening tests used by the coun-
tries. A homogeneous situation would be that where all
countries use the same test in both surveys. Heterogeneity
would appear as soon as, at least, one country uses a dif-
ferent test, with different characteristics, in, at least, one of
the surveys. In our setting, we did not have complete data
on both surveys from all countries. Furthermore, some
countries used more than one test in either survey making
difficult to inform this parameter in the model in such a
way that, for the majority of countries, the variable cap-
tured meaningful variability. We have modelled the test
variability between countries ("test") as the proportion of
ELISA tests over all samples tested, used by each country.
We chose this parameterisation because it was the one for
which more data were available to inform both surveys for
the largest number of countries. Furthermore, we mod-
elled the proportion of the country's adult sheep popula-
tion sampled by the fallen stock ("repreFS") and the
proportion of the adult sheep population sampled by the
abattoir survey ("repreAS") as measures of representative-
ness.
The heterogeneity between studies can also be due to the
baseline risk, in our case the event rate in the abattoir sur-
vey. Differences in the genotype distribution and/or the
survivorship of the slaughtered population between coun-
tries might result in different risks in the abattoir survey.
Thompson et al. [17] and Arends et al. [32] emphasized
the influence of the underlying risk of patients in the dif-
ferent trials/studies upon the treatment benefit we
observe. Warn et al. [31] defined the underlying risk as a
trial-level summary of individual-level characteristics that
would represent the health status of the population sam-
pled by the study. We have assessed the relationship of the
logOR (FS/AS) with the baseline risk (AS) to account for
the potential variability in the risks of the slaughtered
populations between countries on the overall heterogene-
ity.
The combination of a structural dependence between the
outcome and our baseline and the fact that both are esti-
mated from a finite sample (they are measured with error)
present problems associated with regression to the mean,
also known as regression dilution bias. Any of these
events could lead to a biased slope in an ordinary weighed
least squares regression line [32]. The application of the
Bayesian approach facilitates the investigation of the rela-
tionship between the true baseline risk and the true meas-
ure of effect as it models the relationship between the true
parameters rather than observed values.
We extended our previous equations to allow for the cov-
ariates and the baseline, following Sharp and Thompson
[26], into the model
where, for the ith study, θ * is the effect adjusted for the
underlying risk and x the value of the covariate, β and γ
the unconstrained regression coefficients and   the mean
underlying risk across countries. A non-informative prior
distribution, a normal with large variance, must be given
to β and γ. These two parameters, β and γ, are the ones,
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together with the between-country standard deviation (τ),
of principal interest.
We incorporated each covariate, and the baseline, into the
model in a univariate fashion and checked the signifi-
cance of their regression coefficients, whether their 95%
credible intervals included the value zero, and their
impact on the value of τ.
We ran the binomial model in WinBUGS 1.4.1 [33] to
derive, from the marginal posterior distributions of our
parameters of interest, medians, standard deviations and
95% credible intervals. We checked the Gelman-Rubin
plots for convergence.
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